Rebuttal to letter "Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new “prudent” randomised clinical trial" l

Marco Marietta; Armando Tripodi

doi:10.2450/2020.0116-20

Rebuttal to letter "Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new “prudent” randomised clinical trial" l

Fondazione IRCCS Ca' Granda- Ospedale Maggiore Policlinico

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	239-240
Number of pages	2
Journal	Blood Transfusion
Volume	18
Issue number	3
DOIs	https://doi.org/10.2450/2020.0116-20
Publication status	Published - May 2020

ASJC Scopus subject areas

Immunology and Allergy
Hematology

Access to Document

10.2450/2020.0116-20

Cite this

@article{2445f521f2c748008d575066eef1039c,

title = "Rebuttal to letter {"}Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new “prudent” randomised clinical trial{"} l",

author = "Marco Marietta and Armando Tripodi",

year = "2020",

month = may,

doi = "10.2450/2020.0116-20",

language = "English",

volume = "18",

pages = "239--240",

journal = "Blood Transfusion",

issn = "1723-2007",

publisher = "Edizioni SIMTI",

number = "3",

}

TY - JOUR

T1 - Rebuttal to letter "Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new “prudent” randomised clinical trial" l

AU - Marietta, Marco

AU - Tripodi, Armando

PY - 2020/5

Y1 - 2020/5

UR - http://www.scopus.com/inward/record.url?scp=85085158973&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85085158973&partnerID=8YFLogxK

U2 - 10.2450/2020.0116-20

DO - 10.2450/2020.0116-20

M3 - Letter

C2 - 32453693

AN - SCOPUS:85085158973

VL - 18

SP - 239

EP - 240

JO - Blood Transfusion

JF - Blood Transfusion

SN - 1723-2007

IS - 3

ER -